Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Two naturally occurring molecules could be the key to sustained weight management, offering an organic alternative to ...

WeightWatchers announced the departure of CEO Sima Sistani, effective immediately, and board member Tara Comonte, former ...

Should you, would you, take Ozempic? It's a question I'm asked by friends and it's a hot topic among my scientist colleagues, ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

The new weight-loss drugs were originally developed as a treatment ... causing about 15 per cent weight loss. Several other weight-loss pills are also in late-stage trials, and if all goes smoothly, ...

Per Dr. Wheeler, some signs that metformin may not be working are persistently high blood glucose levels and no improvement ...

Discover the revival of the biotech sector, with IPOs resurging and promising weight loss drug potential, despite facing ...

Time-restricted eating may improve blood glucose control and help reduce fat when coupled with standard nutritional ...

Big Joe Henry is managing his cravings and eating healthier with Jersey Weight Loss Clinic, so he's not worried about extra ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...